Odaily Planet Daily News: According to data from MSX.COM, drug development company Sellas Life Sciences surged 220% at opening, after the company announced on Tuesday that its experimental vaccine for a blood cancer showed positive results in a late-stage clinical trial, significantly extending patients' survival time.
Sellas Life Sciences shares surged 220% at market opening
2026-11-17 14:42:02
シェア
免責事項:この記事の著作権は元の作者に帰属し、MyTokenを表すものではありません(www.mytokencap.com)ご意見・ご感想・内容、著作権等ご不明な点がございましたらお問い合わせください。
MyTokenについて:https://www.mytokencap.com/ja/aboutusこの記事へのリンク:https://www.mytokencap.com/ja/choicenews/3662799
community_x_prefix
X(https://x.com/MyTokencap)community_tg_prefixcommunity_tg_name
(https://t.me/mytokenGroup)
X(https://x.com/MyTokencap)community_tg_prefixcommunity_tg_name
(https://t.me/mytokenGroup)